AMGEN INC (AMGN) 253.65 -1.23 (-0.48%)
253.65 -1.23 (-0.48%)
US0311621009 - Common Stock - After market: 253.65 0 (0%)
Buy % Consensus
Analysts have set a mean price target of 275.43. This target is 8.59% above the current price.
AMGN was analyzed by 33 analysts. The buy percentage consensus is at 68. So analysts seem to be have mildly positive about AMGN.
In the previous month the buy percentage consensus was at a similar level.
AMGN was analyzed by 33 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-01-19 | Piper Sandler | Maintains | Overweight |
| 2023-01-18 | Barclays | Maintains | Underweight |
| 2023-01-03 | Wells Fargo | Maintains | Equal-Weight |
| 2022-12-22 | SVB Leerink | Maintains | Market Perform |
| 2022-12-13 | Piper Sandler | Maintains | Overweight |
| 2022-12-06 | Oppenheimer | Maintains | Outperform |
| 2022-11-18 | Credit Suisse | Initiate | Underperform |
| 2022-11-04 | RBC Capital | Maintains | Sector Perform |
| 2022-11-04 | Morgan Stanley | Maintains | Overweight |
| 2022-11-04 | Piper Sandler | Maintains | Overweight |
| 2022-10-31 | Barclays | Downgrade | Equal-Weight -> Underweight |
| 2022-10-12 | Barclays | Maintains | Equal-Weight |
| 2022-10-11 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2022-08-09 | Atlantic Equities | Maintains | Underweight |
| 2022-08-05 | RBC Capital | Maintains | Sector Perform |
| 2022-08-05 | Piper Sandler | Maintains | Overweight |
| 2022-07-15 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-06-01 | Oppenheimer | Maintains | Outperform |
| 2022-05-23 | SVB Leerink | Initiate | Market Perform |
| 2022-05-10 | Mizuho | Maintains | Neutral |
| 2022-04-28 | BMO Capital | Maintains | Market Perform |
| 2022-04-28 | RBC Capital | Maintains | Sector Perform |
| 2022-04-28 | Piper Sandler | Maintains | Overweight |
| 2022-04-12 | Barclays | Maintains | Equal-Weight |
| 2022-04-12 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-02-09 | Oppenheimer | Maintains | Outperform |
| 2022-02-09 | Barclays | Maintains | Equal-Weight |
| 2022-02-09 | Wells Fargo | Maintains | Equal-Weight |
| 2022-02-09 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-01-05 | B of A Securities | Downgrade | Buy -> Neutral |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA